Premium
Pharmacometric Modeling and Simulation Is Essential to Pediatric Clinical Pharmacology
Author(s) -
Neely Michael,
Bayard David,
Desai Amit,
Kovanda Laura,
Edginton Andrea
Publication year - 2018
Publication title -
the journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.92
H-Index - 116
eISSN - 1552-4604
pISSN - 0091-2700
DOI - 10.1002/jcph.1316
Subject(s) - clinical pharmacology , medicine , subspecialty , pharmacology , broad spectrum , specialty , drug development , intensive care medicine , drug , medical physics , family medicine , chemistry , combinatorial chemistry
Pediatric clinical pharmacology now encompasses a wide range of activities, including drug pharmacokinetic and pharmacodynamic modeling and simulation, also known as pharmacometrics. Pediatric clinical pharmacologists may be physicians but are more likely to be pharmacists or PhD scientists, and pediatric clinical pharmacology today is largely a research specialty rather than a subspecialty for direct patient care. Pharmacometrics, including “top‐down” population modeling and “bottom‐up” physiologically based pharmacokinetic modeling, has become an indispensable tool for pharmaceutical industry scientists, government regulators, academic researchers, and even a handful of patient‐oriented practitioners. This review summarizes the application of pharmacometrics within each of these domains and predicts future trends of further applications across the spectrum of pediatric clinical pharmacology from drug development to patient care.